Aegerion Pharmaceuticals Inc. (AEGR): Broadfin Capital Raises Its Stake Ahead of Merger

Page 9 of 10

Page 9 of 10 – SEC Filing
Exhibit A
AGREEMENT
The undersigned agree that this Schedule 13D Amendment, dated September 12, 2016, relating to the Common Stock par value $0.001 of Aegerion Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.
September 12, 2016
————————-
(Date)
BROADFIN CAPITAL, LLC
By:
/s/ Kevin Kotler
Kevin Kotler, Managing Member
KEVIN KOTLER
/s/ Kevin Kotler
BROADFIN HEALTHCARE MASTER FUND, LTD.
By:
/s/ Kevin Kotler
Kevin Kotler, Director

Follow Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR)

Page 9 of 10